Pneumonia burden in severe asthma and COPD with and without inhaled corticosteroid exposure: a real-world comparative cohort study
Background Inhaled corticosteroids (ICS) are central to asthma management and recommended for selected patients with chronic obstructive pulmonary disease (COPD). Comparing pneumonia burden across treatment groups may inform their clinical use. Objective To compare pneumonia burden among patients with severe asthma receiving ICS plus biologic therapy, COPD receiving ICS, and COPD without ICS, and to evaluate the association between ICS exposure and pneumonia within COPD. Methods This single-center retrospective comparative cohort study included 158 adults (50 severe asthma receiving ICS and biologics, 58 COPD receiving ICS, and 50 COPD without ICS) from January 2023–December 2025. Pneumonia was defined using clinical and imaging criteria. COPD-only logistic regression adjusted for age group, sex, and pack-years; exploratory models additionally incorporated BMI, eosinophil count, or individual spirometric indices. Results Pneumonia occurred in 34/158 patients (21.5%): 1/50 (2.0%) with severe asthma, 28/58 (48.3%) with ICS-treated COPD, and 5/50 (10.0%) with COPD without ICS ( p < 0.001). Fifty-eight episodes were recorded, including 52 in ICS-treated COPD. The crude COPD-only OR was 8.40 (95% CI 2.92–24.19). In 95 complete cases (30 pneumonia events), the adjusted OR was 10.06 (95% CI 2.99–33.80); with additional BMI adjustment it was 10.38 (2.97–36.20), with eosinophil adjustment 11.32 (3.19–40.20), and with both 11.93 (3.21–44.36). Conclusions ICS-treated COPD patients had a substantially greater pneumonia burden than those managed without ICS. The association persisted after adjustment for available demographic, smoking, and lung function variables, supporting attention to pneumonia burden during individualized ICS treatment review. The severe asthma comparison was descriptive; residual confounding and wide confidence intervals warrant cautious interpretation of the association.
Authors
- Saltuk Buğra Kaya (ORCID: https://orcid.org/0000-0002-3890-1299)
- Yunus Emre Er
- Betül Inal
- Dilara Sevval Saglik
- Ipek Balikçi Çiçek
Institutions
- Inonu University (TR)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fmed.2026.1957185
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00